CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
Medtronic Activa PC+S System with Chronic Neural Recording +3 moredevice
Likely dose
Medtronic Activa PC+S System with ECoG electrodes implanted in basal ganglia (subthalamic nucleus or globus pallidus internus) and prefrontal cortex; high-frequency stimulation parameters not specified in published textAI-extracted
Key inclusion· 6
  • Age 30-75 years
  • Parkinson's disease diagnosed by movement disorders specialist
  • Motor symptoms severe enough to warrant DBS surgery per standard clinical criteria, with UPDRS-III off-medication score 20-80 and ≥30% improvement on medication, OR tremor-dominant PD with tremor score ≥2 and treatment resistance, OR medication intolerance
  • Mild to moderate mood or impulsive behavior: depression (BDI ≥13), anxiety (BAI ≥7), impulsivity (positive QUIP-A or clinical assessment), or mood fluctuations with ≥30% improvement in VAS scores on versus off medication
Key exclusion· 11
  • Pregnancy or breastfeeding
  • MRI showing cortical atrophy out of proportion to age
  • MRI showing focal brain lesions indicating disorder other than idiopathic PD
  • Major comorbidity increasing surgical risk: prior stroke, severe hypertension, severe diabetes, or chronic anticoagulation other than aspirin

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03131817
NCT03131817N/ACompleted

Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's

Simon J. Little, MBBS, PhD·interventional·Posted Apr 27, 2017·Updated Nov 21, 2025

In Brief

A clinical study evaluating Medtronic Activa PC+S System with Chronic Neural Recording, Effort-Reward Decision-Making Task, and 2 other interventions for Parkinson's Disease. Completed, enrolled 5 participants across 1 site.

Detailed Summary

This study will investigate cortical stimulation to treat mood and behavioral symptoms in Parkinson's disease patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 27, 2017
Enrollment StartDec 16, 2016
Primary CompletionJun 18, 2024
TodayJul 2, 2026
Enrollment to primary: 7.5 yearsPosted 9.2 years ago

Interventions

Medtronic Activa PC+S System with Chronic Neural Recordingdevice

Participants received a Medtronic Activa PC+S system incorporating standard-of-care DBS leads implanted in the basal ganglia (subthalamic nucleus or globus pallidus internus) for management of Parkinson's disease motor symptoms. Additionally, a permanent 4-contact subdural electrocorticography (ECoG) strip was implanted over the prefrontal cortex (e.g., dorsolateral, orbitofrontal, or frontopolar regions) to enable chronic recording of local field potentials. The system allowed for long-term, wireless neural recordings in naturalistic or task-based conditions.

Effort-Reward Decision-Making Taskbehavioral

Participants performed a structured task involving repeated choices to accept or reject offers requiring different levels of physical effort in exchange for variable rewards. The task was used to assess motivation and effort-based valuation processes.

Prefrontal Cortex Stimulationother

In one participant, high-frequency stimulation was delivered to the prefrontal cortex via the ECoG strip during a behavioral paradigm. Stimulation was alternated On and Off in a blinded block-wise fashion during the behavioral task to assess causal effects on motivated behavior. In two patients, orbitofrontal cortex (OFC) stimulation was also assessed chronically at home in a within subject, repeated design.

Tablet-Based Mood Tracking (Immediate Mood Scaler)behavioral

Participants used a tablet-based Immediate Mood Scaler (IMS) to self-report symptoms related to depression and anxiety in real-time, naturalistic settings. These repeated, in-the-moment assessments were temporally paired with prefrontal cortical recordings to study physio markers of mood fluctuations over several months. No stimulation was delivered through the prefrontal cortex electrode.